Evidence map›Paper›PMID 37223506›Full record

ArticleGenes & diseases2023

BAF45D regulates spinal cord neural stem/progenitor cell fate through the SMAD-PAX6 axis.

Xueying Chen, Xiujuan Hu, Jing Jiang, Jie Tao, Lihua Liu, Shengyun Fang, Yuxian Shen, Qingsong Hu, Chao Liu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xueying ChenSchool of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
Xiujuan HuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
Jing JiangSchool of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
Jie TaoDivision of Life Sciences and Medicine, University of Science and Technology of China, The First Affiliated Hospital of USTC, Hefei, Anhui 230001, China.
Lihua LiuInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, Anhui 230032, China.
Shengyun FangCenter for Biomedical Engineering and Technology, University of Maryland, Baltimore, MD 21201, USA.
Yuxian ShenSchool of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
Qingsong HuDivision of Life Sciences and Medicine, University of Science and Technology of China, The First Affiliated Hospital of USTC, Hefei, Anhui 230001, China.
Chao LiuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
Anhui Medical University · CNUniversity of Science and Technology of China · CNUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37223506
PMCPMC10201662
OpenAlexW4286681043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.